Renee N Donahue

19PUBLICATIONS
111CO-AUTHORS
Molecular targetsTumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersTissue engineering
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Jul 24, 2026
Durable responses to triplet immunotherapy targeting TGF-β, PD-L1, and tumor antigen, with an IL-15 receptor superagonist in mismatch repair proficient castration-resistant prostate cancer.

|Apr 22, 2026
Blockade of Tumor-Intrinsic TGFβ Signaling Drives Hyperprogression in Small Cell Lung Cancer.

|Mar 25, 2026
Phase II study of olaparib and durvalumab in patients with metastatic castration-resistant prostate cancer.

Chennan Li, Ravi A Madan, Min-Jung Lee

|Aug 01, 2025
Increased Peripheral T Stem Cell-like Memory Features in Patients with Advanced Solid Tumors Treated with Tumor-Targeting IL-12 Immunocytokine Therapy.

Meghali Goswami, Carolina Celades, Christine M Minnar

|Jun 23, 2025
Programmed death-1 inhibition increases vaccine-induced T-cell infiltration in patients with prostate cancer.

Wiem Lassoued, Ravi A Madan, Elisabetta Xue

|May 13, 2025
Combination of a therapeutic cancer vaccine targeting the endogenous retroviral envelope protein ERVMER34-1 with immune-oncology agents facilitates expansion of neoepitope-specific T cells and promotes tumor control.

Maria Del Mar Maldonado, Maria Gracia-Hernandez, Loc Huu Le

Pageof 4

Frequent Collaborators

18 joint publications

Jeffrey Schlom

11 joint publications

James L Gulley

7 joint publications

Yo-Ting Tsai

5 joint publications

Nicole J Toney